Shanghai RAAS Blood Products Co Ltd Class A (002252) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.026x

Based on the latest financial reports, Shanghai RAAS Blood Products Co Ltd Class A (002252) has a cash flow conversion efficiency ratio of -0.026x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-843.75 Million ≈ $-123.47 Million USD) by net assets (CN¥32.46 Billion ≈ $4.75 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See debt-free asset ratio of Shanghai RAAS Blood Products Co Ltd Clas to measure how much of total assets are equity-financed.

Shanghai RAAS Blood Products Co Ltd Class A - Cash Flow Conversion Efficiency Trend (2005–2025)

This chart illustrates how Shanghai RAAS Blood Products Co Ltd Class A's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Shanghai RAAS Blood Products Co Ltd Clas cash earnings quality to evaluate the quality of earnings relative to operating cash generation.

Shanghai RAAS Blood Products Co Ltd Class A Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Shanghai RAAS Blood Products Co Ltd Class A ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
INPOST S.A. EO -01
F:669
N/A
Parkland Fuel Corporation
TO:PKI
0.158x
Compagnie Generale des Etablissements Michelin SCA
LSE:0OFM
0.069x
Enstar Group Limited
NASDAQ:ESGR
0.023x
Acm Research Inc
NASDAQ:ACMR
-0.014x
CHINA TOWER UNSP.ADR/100
F:2Y10
N/A
LS Corp
KO:006260
0.078x
Corporacion Financiera Alba SA
MC:ALB
0.006x

Annual Cash Flow Conversion Efficiency for Shanghai RAAS Blood Products Co Ltd Class A (2005–2025)

The table below shows the annual cash flow conversion efficiency of Shanghai RAAS Blood Products Co Ltd Class A from 2005 to 2025. For the full company profile with market capitalisation and key ratios, see Shanghai RAAS Blood Products Co Ltd Clas market cap and net worth.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 CN¥32.47 Billion
≈ $4.75 Billion
CN¥-104.89 Million
≈ $-15.35 Million
-0.003x +78.59%
2024-12-31 CN¥31.94 Billion
≈ $4.67 Billion
CN¥-482.06 Million
≈ $-70.54 Million
-0.015x -119.64%
2023-12-31 CN¥29.65 Billion
≈ $4.34 Billion
CN¥2.28 Billion
≈ $333.33 Million
0.077x +28.28%
2022-12-31 CN¥28.81 Billion
≈ $4.22 Billion
CN¥1.73 Billion
≈ $252.51 Million
0.060x +19.89%
2021-12-31 CN¥25.90 Billion
≈ $3.79 Billion
CN¥1.29 Billion
≈ $189.35 Million
0.050x +7.40%
2020-12-31 CN¥25.13 Billion
≈ $3.68 Billion
CN¥1.17 Billion
≈ $171.04 Million
0.047x -38.76%
2019-12-31 CN¥11.49 Billion
≈ $1.68 Billion
CN¥872.69 Million
≈ $127.70 Million
0.076x +215.35%
2018-12-31 CN¥10.90 Billion
≈ $1.60 Billion
CN¥262.50 Million
≈ $38.41 Million
0.024x +11.83%
2017-12-31 CN¥12.48 Billion
≈ $1.83 Billion
CN¥268.76 Million
≈ $39.33 Million
0.022x -60.42%
2016-12-31 CN¥11.73 Billion
≈ $1.72 Billion
CN¥638.22 Million
≈ $93.39 Million
0.054x -23.55%
2015-12-31 CN¥10.71 Billion
≈ $1.57 Billion
CN¥762.42 Million
≈ $111.57 Million
0.071x +31.73%
2014-12-31 CN¥8.62 Billion
≈ $1.26 Billion
CN¥465.96 Million
≈ $68.18 Million
0.054x +166.06%
2013-12-31 CN¥1.10 Billion
≈ $161.22 Million
CN¥-90.11 Million
≈ $-13.19 Million
-0.082x -131.65%
2012-12-31 CN¥1.02 Billion
≈ $149.18 Million
CN¥263.46 Million
≈ $38.55 Million
0.258x +34.61%
2011-12-31 CN¥927.27 Million
≈ $135.69 Million
CN¥178.03 Million
≈ $26.05 Million
0.192x -20.29%
2010-12-31 CN¥831.21 Million
≈ $121.63 Million
CN¥200.21 Million
≈ $29.30 Million
0.241x +58.49%
2009-12-31 CN¥763.33 Million
≈ $111.70 Million
CN¥116.01 Million
≈ $16.98 Million
0.152x +6.57%
2008-12-31 CN¥754.76 Million
≈ $110.45 Million
CN¥107.64 Million
≈ $15.75 Million
0.143x -86.20%
2007-12-31 CN¥170.01 Million
≈ $24.88 Million
CN¥175.71 Million
≈ $25.71 Million
1.034x +202.38%
2006-12-31 CN¥156.77 Million
≈ $22.94 Million
CN¥53.58 Million
≈ $7.84 Million
0.342x +46.61%
2005-12-31 CN¥231.70 Million
≈ $33.90 Million
CN¥54.02 Million
≈ $7.90 Million
0.233x --

About Shanghai RAAS Blood Products Co Ltd Class A

SHE:002252 China Biotechnology
Market Cap
$5.03 Billion
CN¥34.38 Billion CNY
Market Cap Rank
#3525 Global
#482 in China
Share Price
CN¥5.18
Change (1 day)
-0.77%
52-Week Range
CN¥4.31 - CN¥7.18
All Time High
CN¥24.72
About

Shanghai RAAS Blood Products Co., Ltd., together with its subsidiaries, produces and sells blood products in China and internationally. The company offers ALBURAAS, which is albumin prepared from human plasma; GAMARAAS, a human immunoglobulin product for intravenous injections; HEMORAAS, a human coagulation factor VIII product; PROTHORAAS, a human prothrombin complex; FIBRORAAS, a human fibrinoge… Read more